Recent research has highlighted that reduced levels of sex hormone-binding globulin (SHBG) in the bloodstream are linked to higher susceptibility to obesity, insulin resistance, and diabetes, potentially contributing to broader metabolic imbalances
Instead, clinicians are entering an era where diabetes care and hepatology increasingly overlap, especially as metabolic dysfunction-associated steatotic liver disease, or MASLD, becomes Read More When GLP-1 Therapy Plateaus: What Clinicians Should Do Next May 13, 2026 Articles, Blood Glucose Control, Blood Glucose Control, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Type 2 Diabetes, Type 2 Diabetes 2,481 views Everything seems to be working perfectly until it suddenly isnt
doi: 10.1089/thy.2009.0351 55 ZuoYLiYGuXLeiZ
10.1016/j.ebiom.2023.104642 5 ArcegoD